Evidence map›Paper›PMID 23233123›Full record

ArticleJournal of immigrant and minority health2013

Should we look for Strongyloides stercoralis in foreign-born HIV-infected persons?

Jara Llenas-García, Silvana Fiorante, Efrén Salto, Diego Maseda, Violeta Rodríguez, Mariano Matarranz, Asunción Hernando, Rafael Rubio, Federico Pulido

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of immigrant and minority health, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Concomitant Serological and Molecular Methods forTropical medicine and infectious disease · 2024
    Article
  4. Observational
  5. Article
  6. Article
  7. Soil-Transmitted Helminths in Tropical Australia and Asia.Tropical medicine and infectious disease · 2017
    Review
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jara Llenas-GarcíaHIV Unit, Instituto de Investigación Hospital 12 de Octubre (i + 12), Universidad Complutense de Madrid, Madrid, Spain. jaravih12@gmail.com
Silvana Fiorante
Efrén Salto
Diego Maseda
Violeta Rodríguez
Mariano Matarranz
Asunción Hernando
Rafael Rubio
Federico Pulido

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective was to evaluate the implementation of a systematic Strongyloides stercoralis screening programme in HIV infected immigrants attending an HIV Unit in Spain. An enzyme-linked immunosorbent assay (ELISA) was performed to assess the presence of Strongyloides IgG. Patients with a positive serology were treated with ivermectin; serologic follow-up testing was performed. 237 patients were screened (65.4 % men). Origin: 64.1 % came from Latin America, 16.5 % from Sub-Saharan Africa, 9.7 % from the Caribbean, 9.7 % from other areas. Strongyloides stercolaris IgG was positive in 13 cases (5.5 %). In the multivariate analysis, factors associated with a positive Strongyloides serology were illiteracy (OR: 23.31; p = 0.009) and eosinophilia (OR: 15.44; p < 0.0001). Nine of the 13 patients positive for S. stercoralis IgG and treated with ivermectin had a follow up serologic test: 77.8 % achieved a serologic response (55.5 % seroreversion). Screening of HIV-positive immigrants may be desirable, at least in those with higher risk of hyperinfection syndrome. Serologic testing seems a useful tool in both diagnosis and follow-up of these patients.

Indexed as

AdultAfrica South of the SaharaAnimalsCaribbean RegionCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin GIvermectinLatin AmericaLongitudinal StudiesMaleMass ScreeningMiddle AgedSpainImmunoglobulin GIvermectin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.